STAAR Surgical Company (STAA)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $1.32B
Last updated: Nov 17, 2026 at 11:05 AM ET
STAAR Surgical Company (STAA) P/E Ratio & Valuation History
STAAR Surgical Company (STAA) trades at 35.2x trailing earnings and 4.0x sales. Its P/S of 4.0x is below its 5-year median of 5.7x. Its forward P/E is 47.2x. The median P/E across 8 similar companies is 24.6x.
Current Multiples
Its forward P/E is above its trailing P/E, which implies earnings per share about 25.4% lower over the next year. Its free cash flow yield is 1.4%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 35.2x |
| Forward P/E | 47.2x |
| Price to sales | 4.0x |
| Price to book | 3.5x |
| EV/EBITDA | 92.1x |
| Price to FCF | 73.7x |
| EV/FCF | 66.2x |
| PEG | 0.8 |
| FCF yield | 1.4% |
Historical Medians
Against its 10-year medians, its P/S is 51.8% below 8.3x and its P/B is 66.3% below 10.4x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 4.0x | 5.7x | 8.3x |
| P/B | 3.5x | 4.3x | 10.4x |
Valuation History
Over the 6 of the 10 year ends shown that have a P/E, its P/E ranged from 30.0x in 2023 to 220.1x in 2020. 2023 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $23.09 | N/A | 4.8x | 3.3x |
| 2024 | $24.29 | N/A | 3.8x | 3.0x |
| 2023 | $31.21 | 30.0x | 4.7x | 4.0x |
| 2022 | $48.54 | 39.8x | 8.2x | 7.1x |
| 2021 | $91.30 | 104.9x | 18.9x | 17.5x |
| 2020 | $79.22 | 220.1x | 22.5x | 19.6x |
| 2019 | $35.17 | 74.8x | 10.6x | 10.3x |
| 2018 | $31.91 | 118.2x | 11.1x | 11.3x |
| 2017 | $15.50 | N/A | 7.0x | 14.9x |
| 2016 | $10.85 | N/A | 5.3x | 11.6x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About STAA
What is STAA's forward P/E ratio?
STAAR Surgical Company has a forward P/E ratio of 47.2x.
Is STAA stock overvalued?
GNG's valuation label for STAA is Undervalued. Its P/E of 35.2x compares with a median of 24.6x across 8 similar companies.
What is STAA's price to sales ratio?
STAAR Surgical Company has a price to sales ratio of 4.0x.
What is STAA's PEG ratio?
STAAR Surgical Company has a PEG ratio of 0.8.
STAA pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts